IgAN may have already caused considerable kidney damage by the time it is diagnosed. This is particularly concerning given that patients are often diagnosed between 30 and 40 years of age1, leaving potentially several decades during which their remaining kidney function needs to be protected.

In a recent survey conducted on behalf of Ipsos among 25 US-based nephrologists, respondents estimated that an average of 47% of newly diagnosed IgAN patients experienced delays in disease identification, referral or diagnosis that may have reduced their opportunity for better long-term kidney outcomes.

This points to a critical challenge: enabling timely specialist assessment for patients with possible IgAN, so that a diagnosis can be established while there is still kidney function to preserve.